An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

被引：0

作者：

Sevindik, Omur Gokmen ^{[1
]}

Ozkurt, Zubeyde Nur ^{[2
]}

Boga, Can ^{[3
]}

Besisik, Sevgi Kalayoglu ^{[4
]}

Ipek, Yildiz ^{[5
]}

Geduk, Ayfer ^{[6
]}

Harmandali, Aybuke ^{[7
]}

Salihoglu, Ayse ^{[8
]}

Sahin, Handan Haydaroglu ^{[9
]}

Sonmez, Mehmet ^{[10
]}

Vural, Filiz ^{[11
]}

Akay, Olga Meltem ^{[12
]}

Yuksel, Meltem Kurt ^{[13
]}

Maral, Senem ^{[14
]}

Ekinci, Omer ^{[15
]}

Kirkizlar, Hakki Onur ^{[16
]}

Tekinalp, Atakan ^{[17
]}

Demir, Nazli ^{[18
]}

Merter, Mustafa ^{[15
]}

Saydam, Guray ^{[11
]}

Alacacioglu, Inci ^{[19
]}

Yegin, Zeynep Arzu ^{[2
]}

Kasar, Mutlu ^{[3
]}

Mastanzade, Metban ^{[20
]}

Ozsan, Guner Hayri ^{[19
]}

机构：

[1] Medipol Univ, Istanbul, Turkey

[2] Gazi Univ, Fac Med, Ankara, Turkey

[3] Baskent Univ Hosp, Ankara, Turkey

[4] Istanbul Univ, Div Hematol, Dept Internal Med, Fac Med, Istanbul, Turkey

[5] Dr Lutfi Kartal City Hosp, Istanbul, Turkey

[6] Kocaeli Univ, Fac Med, Izmit, Turkey

[7] Tepecik Educ & Res Hosp, Izmir, Turkey

[8] Istanbul Univ Cerrahpasa, Fac Med, Istanbul, Turkey

[9] Gaziantep Univ, Sahinbey Res & Practice Hosp, Gaziantep, Turkey

[10] Karadeniz Tech Univ, Fac Med, Trabzon, Turkey

[11] Ege Univ, Fac Med, Bornova, Turkey

[12] Koc Univ Hosp, Istanbul, Turkey

[13] Ankara Univ, Fac Med, Ankara, Turkey

[14] Diskapi Yildirim Beyazit Training & Res Hosp, Ankara, Turkey

[15] Firat Univ, Fac Med, Elazig, Turkey

[16] Trakya Univ, Fac Med, Edirne, Turkey

[17] Meram Univ, Fac Med, Konya, Turkey

[18] Istanbul Sisli Hamidiye Etfal Educ & Res Hosp, Istanbul, Turkey

[19] Dokuz Eylul Univ, Fac Med, Alsancak, Turkey

[20] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-125

引用

页码：S102 / S103

页数：2

共 50 条

[1] An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy
Sevindik, Omur Gokmen
Ozkurt, Zubeyde Nur
Boga, Can
Besisik, Sevgi Kalayoglu
Ipek, Yildiz
Geduk, Ayfer
Harmandali, Aybuke
Salihoglu, Ayse
Sahin, Handan Haydaroglu
Sonmez, Mehmet
Vural, Filiz
Akay, Olga Meltem
Yuksel, Meltem Kurt
Maral, Senem
Ekinci, Omer
Kirkizlar, Hakki Onur
Tekinalp, Atakan
Demir, Nazli
Merter, Mustafa
Saydam, Guray
Alacacioglu, Inci
Yegin, Zeynep Arzu
Kasar, Mutlu
Mastanzade, Metban
Ozsan, Guner Hayri
BLOOD, 2021, 138
[2] PRIMARY HYPERPARATHYROIDISM IN PATIENTS WHO HAVE, RECEIVED RADIATION-THERAPY AND IN PATIENTS WHO HAVE, NOT RECEIVED RADIATION-THERAPY
TEZELMAN, S
RODRIGUEZ, JM
SHEN, W
SIPERSTEIN, AE
DUH, QY
CLARK, OH
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1995, 180 (01) : 81 - 87
[3] Teclistamab as monotherapy in patients with relapsed or refractory multiple myeloma who received three or more lines of therapy
Le Grand, Sophie
Karlin, Lionel
BULLETIN DU CANCER, 2023, 110 (09) : 871 - 872
[4] Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US
Rafael Fonseca
May Hagiwara
Sumeet Panjabi
Emre Yucel
Jacqueline Buchanan
Thomas Delea
Blood Cancer Journal, 11
[5] Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US
Fonseca, Rafael
Hagiwara, May
Panjabi, Sumeet
Yucel, Emre
Buchanan, Jacqueline
Delea, Thomas
BLOOD CANCER JOURNAL, 2021, 11 (02)
[6] A COMPREHENSIVE COST-EFFECTIVENESS ANALYSIS OF LENALIDOMIDE FOR MULTIPLE MYELOMA PATIENTS WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY
Felix, J.
Almeida, J.
Vandewalle, B.
VALUE IN HEALTH, 2012, 15 (04) : A218 - A218
[7] THE NEED TO IDENTIFY PATIENTS WHO HAVE RECEIVED STREPTOKINASE THERAPY
SALEM, DN
PAUKER, SG
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (24): : 1742 - 1742
[8] Economic evaluation of lenalidomide for the treatment of multiple myeloma in Scotland in patients who have received one prior therapy
Deniz, B.
Ishak, K. J.
Shearer, A.
Dale, P.
Caro, J. J.
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 29 - 30
[9] Burden of Disease Progression in Patients with Multiple Myeloma Who Have Received at Least One Line of Therapy in the US
Hagiwara, May
Delea, Thomas
Panjabi, Sumeet
Yucel, Emre
Fonseca, Rafael
BLOOD, 2018, 132
[10] Economic evaluation of lenolidomide use for multiple myeloma in Scotland in patients who have received one prior therapy
Deniz, B.
Ishak, K. J.
Shearer, A.
Dale, P.
Caro, J. J.
VALUE IN HEALTH, 2008, 11 (03) : A156 - A156

← 1 2 3 4 5 →